Ann M. Hanly is CTO at Vir Biotechnology, Inc. (VIR). They have made 7 open-market trades across 1 company since 2021, most recently 2025-02-24.
CIK 0001854528
1 open-market purchase totalling $500 since 2021, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIR | 117,901 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2025-02-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL | 2025-02-24 | 2025-02-25 | $9.45 | $268K | -11.8% | -26.1% | -48.4% |
| VIR | SELL | 2024-04-01 | 2024-04-02 | $10.05 | $27K | -5.3% | -3.1% | -3.9% |
| VIR | SELL | 2024-02-22 | 2024-02-26 | $10.05 | $247K | -6.2% | -15.8% | -10.6% |
| VIR | SELL | 2023-03-30 | 2023-03-31 | $22.77 | $120K | +7.0% | +8.8% | +7.9% |
| VIR | SELL | 2023-02-23 | 2023-02-24 | $25.97 | $120K | -0.4% | +1.1% | +13.3% |
| VIR | SELL | 2022-03-30 | 2022-03-31 | $26.24 | $138K | -15.4% | -19.2% | +0.7% |
| VIR | BUY | 2021-11-29 | 2021-12-01 | $45.44 | $500 | -15.5% | -20.4% | -54.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.